CAR T Cell Treatment

It is a current targeted therapy used in treatment-resistant or recurrent cases of diseases such as leukemia and lymphoma. In this treatment method, T lymphocyte cells of the patient’s own immune system are taken and separated. By increasing the number of these T cells, they are modified to kill malignant cells directly. The treatment performed by giving these specially produced cells (CAR T CELL), which can directly kill malignant cells, back to the person through blood is called CAR T CELL treatment. It has gained momentum in the last decade and has become a source of hope, especially for patients who do not receive adequate response with standard treatment methods. It is generally used as a bridge treatment to bone marrow transplantation. Car T Cell therapy can be produced individually in academic settings and is now available as a ready-made product. Enhanced T Lymphocyte cells fight cancer cells better in the body. In order to perform these procedures, it is vital to take the patient’s blood in the hospital, prepare the body for this process with medication while the cells are being produced, close monitoring of the body after the T lymphocytes are returned, and close follow-up of the treatment response. This procedure should be performed in areas where intensive care and hematology oncology teams trained in this field work together.